Normalization of blood pressure and renal vascular resistance in shr with a membrane-permeable superoxide dismutase mimetic role of nitric oxide

Hypertension

Volumn 32, Issue 1, 1998, Pages 59-64

  Schnackenberg, Christine G ^a   Welch, William J ^a   Wilcox, Christopher S ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antioxidants; Blood pressure; Free radicals; Nitric oxide; Superoxide dismutase; Tempol

Indexed keywords

ANTIOXIDANT; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NORADRENALIN; SUPEROXIDE; SUPEROXIDE DISMUTASE; TEMPOL;

AGONIST; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; HYPERTENSION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; KIDNEY VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; MEMBRANE PERMEABILITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; VASOCONSTRICTION;

EID: 0031926961     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.32.1.59     Document Type: Article

References (38)

1. Bulpitt CJ. Vitamin C and blood pressure. J Hypertens. 1990;8:1071-1075.
2. Ceriello A, Giugliano D, Quatraro A, Lefebvre PJ. Anti-oxidants show anti-hypertensive effect in diabetic and hypertensive subjects. Clin Sci. 1991;81:739-742.
3. Galley HF, Thornton J, Howdle PD, Walker BE, Webster NR. Combination oral antioxidant supplementation reduces blood pressure. Clin Sci. 1997;92:361-365.
4. Suzuki H, Swei A, Zweifach BW, Schmid-Schönbein GW. In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats: hydroethidine microfluorography. Hypertension. 1995;25:1083-1089.
5. Auch-Schwelk W, Katusic ZS, Vanhoutte PM. Contractions to oxygen-derived free radicals are augmented in aorta of the spontaneously hypertensive rat. Hypertension. 1989;13:859-864.
6. Yoshioka M, Aoyama K, Matsushita T. Effects of ascorbic acid on blood pressure and ascorbic acid metabolism in spontaneously hypertensive rats. Int J Vitam Nutr Res. 1985;55:301-307.
7. Miyamoto Y, Akaike T, Yoshida M, Goto S, Horie H, Maeda H. Potentiation of nitric oxide-mediated vasorelaxation by xanthine oxidase inhibitors. Proc Soc Exp Biol Med. 1996;211:366-373.
8. Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T, Inque M. Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci U S A. 1991;88:10045-10048.
9. Hayakawa H, Hirata Y, Suzuki E, Kakoki M, Kikuchi K, Nagano T, Hirobe M, Omata M. Endothelium-derived relaxing factors in the kidney of spontaneously hypertensive rats. Life Sci. 1995;56:401-408.
10. Mayhan WG. Impairment of endothelium-dependent dilatation of basilar artery during chronic hypertension. Am J Physiol. 1990;259: H1455-H1462.
11. Luscher TF, Diederich D, Weber E, Vanhoutte PM, Buhler FR. Endothelium-dependent responses in carotid and renal arteries of normotensive and hypertensive rats. Hypertension. 1988;11:573-578.
12. Dohi Y, Thiel MA, Buhler FR, Luscher TF. Activation of endothelial L-arginine pathway in resistance arteries: effect of age and hypertension. Hypertension. 1990;15:170-179.
13. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 1986;320:454-456.
14. Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol. 1986;250: H822-H827.
15. Tschudi MR, Mesaros S, Luscher TF, Malinski T. Direct in situ measurement of nitric oxide in mesenteric resistance arteries: increased decomposition of superoxide in hypertension. Hypertension. 1996;27: 32-35.
16. Grunfeld S, Hamilton CA, Mesaros S, McClain SW, Dominiczak AF, Bohr DF, Malinski T. Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension. 1995;26(pt 1):854-857.
17. Iannone A, Bini A, Swartz HM, Tomasi A, Vannini V. Metabolism in rat liver microsomes of the nitroxide spin probe tempol. Biochem Pharm. 1989;38:2581-2586.
18. Nilsson UA, Olsson LI, Carlin G, Bylund-Fellenius AC. Inhibition of lipid peroxidation by spin labels: relationships between structure and function. J Biol Chem. 1989;19:11131-11135.
19. Gelvan D, Saltman P, Powell SR. Cardiac reperfusion damage prevented by a nitroxide free radical. Proc Natl Acad Sci U S A. 1991;88:4680-4684.
20. Karmeli F, Eliakim R, Okon E, Samuni A, Rachmilewitz D. A stable nitroxide radical effectively decreases mucosal damage in experimental colitis. Gut. 1995;37:386-393.
21. Goffman T, Cuscela D, Glass J, Hahn S, Krishna CM, Lupton G, Mitchell JB. Topical application of nitroxide protects radiation-induced alopecia in guinea pigs. Radiat Oncol Biol Phys. 1992;22:803-806.
22. Hahn SM, Tochner Z, Krishna CM, Glass J, Wilson L, Samuni A, Sprague M, Venzon D, Glatstein E, Mitchell JB, Russo A. Tempol, a stable free radical, is a novel murine radiation protector. Cancer Res. 1992;52:1750-1753.
23. Mitchell JB, DeGraff W, Kaufman D, Krishna MC, Samuni A, Finkelstein E, Ahn MS, Hahn SM, Gamson J, Russo A. Inhibition of oxygen-dependent radiation-induced damage by the nitroxide superoxide dismutase mimic, tempol. Arch Biochem Biophys. 1991; 289:62-70.
24. Welch WJ, Deng X, Snellen H, Wilcox CS. Validation of miniature ultrasonic transit-time flow probes for measurement of renal blood flow in rats. Am J Physiol. 1995;37:F175-F178.
25. Maxwell SRJ. Prospects for the use of antioxidant therapies. Drugs. 1995;49:345-361.
26. Henson PE, Johnston RB. Tissue injury in inflammation: oxidants, proteinases, and cationic proteins. J Clin Invest. 1987;79:669-674.
27. Carew TE, Schwenke DC, Steinberg D. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks slowing the progression of atherosclerosis in the WHHL rabbit. Proc Natl Acad Sci U S A. 1987;84: 7725-7729.
28. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med. 1985;312:159-163.
29. Mitchell JB, Samuni A, Krishna MC, DeGraff WG, Ahn MS, Samuni U, Russo A. Biologically active metal-independent superoxide dismutase mimics. Biochemistry. 1990;29:2802-2807.
30. Samuni A, Winkelsberg D, Pinson A, Hahn SM, Mitchell JB, Russo A. Nitroxide stable radicals protect beating cardiomyocytes against oxidative damage. Clin Invest. 1991;87:1526-1530.
31. Pou S, Pou WS, Bredt DS, Snyder SH, Rosen GM. Generation of superoxide by purified brain nitric oxide synthase. J Biol Chem. 1992; 267:24173-24176.
32. Baylis C, Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest. 90:278-281:1992.
33. Granger JP, Alberola AM, Salazar FJ, Nakamura T. Control of renal hemodynamics during intrarenal and systemic blockade of nitric oxide synthesis in conscious dogs. J Cardiovasc Pharmacol. 1992;20:S160-S162.
34. Haynes WG, Noon JP, Walker BR, Webb DJ. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J Hypertens. 1993; 11:1375-1380.
35. Ito S, Carretero OA. Impaired response to acetylcholine despite intact endothelium-derived relaxing factor/nitric oxide in isolated perfused afferent arterioles of the spontaneously hypertensive rat. J Cardiovasc Pharmacol. 1992;20:S187-S189.
36. Mishira OP, Kovachich GB. Inhibition of the autoxidation of ascorbate and norepinephrine by extracts of Clostridium butyricum, Megasphera elsdenii and Escherichia coli. Life Sic. 1984;35:849-854.
37. Konorev EA, Tarpey MM, Joseph J, Baker JE, Kalyanaraman B. Nitronyl nitroxides as probes to study the mechanism of vasodilatory action of nitrovasodilators, nitrone spin traps, and nitroxides: role of nitric oxide. Free Radic Biol Med. 1995;18:169-177.
38. Landino LM, Crews BC, Timmons MD, Morrow JD, Marnett LJ. Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. Proc Natl Acad Sci U S A. 1996;93:15069-15074.